Northwestern University Feinberg School of Medicine is the medical school of Northwestern University and is located in the Streeterville neighborhood of Chicago, Illinois.

During the past decade, Northwestern University Feinberg School of Medicine conducted 208 clinical trials. In the 10-year time frame, 208 clinical trials started and 126 clinical trials were completed, i.e. on average, 60.6% percent of trials that started reached the finish line to date. In the past 5 years, 88 clinical trials started and 78 clinical trials were completed. i.e. 88.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwestern University Feinberg School of Medicine" #1 sponsor was "Northwestern University" with 88 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 64 trials sponsored, "Bristol-Myers Squibb" with 16 trials sponsored, "Celgene" with 11 trials sponsored and "Pfizer" with 11 trials sponsored. Other sponsors include 264 different institutions and companies that sponsored additional 196 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern University Feinberg School of Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 13 trials as a collaborator, "Bristol-Myers Squibb" with 9 trials as a collaborator, "National Institutes of Health (NIH)" with 8 trials as a collaborator, "Glaxo Wellcome" with 6 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 6 trials as a collaborator. Other collaborators include 232 different institutions and companies that were collaborators in the rest 155 trials.

According to Clinical.Site data, the most researched conditions in "Northwestern University Feinberg School of Medicine" are "HIV Infections" (85 trials), "Eosinophilic Esophagitis" (8 trials), "Amyotrophic Lateral Sclerosis" (7 trials), "Crohn's Disease" (7 trials) and "Osteoporosis" (7 trials). Many other conditions were trialed in "Northwestern University Feinberg School of Medicine" in a lesser frequency.

Most popular intervention types in "Northwestern University Feinberg School of Medicine" are "Drug" (329 trials), "Biological" (46 trials), "Other" (32 trials), "Behavioral" (27 trials) and "Device" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (70 trials), "Zidovudine" (26 trials), "Indinavir sulfate" (12 trials), "Didanosine" (11 trials) and "Stavudine" (11 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern University Feinberg School of Medicine" are 426 trials for "All" genders, 20 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 86 active trials in "Northwestern University Feinberg School of Medicine". 1 are not yet recruiting, 54 are recruiting, 28 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 288 completed trials in Northwestern University Feinberg School of Medicine, 1 suspended trials, and 62 terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern University Feinberg School of Medicine, 64 "Phase 1" clinical trials were conducted, 184 "Phase 2" clinical trials and 108 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 27 trials, and there were also 71 trials that are defined as “Not Applicable".